{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["12(6)"],"submitter":["Poisson J"],"pubmed_abstract":["<h4>Background</h4>Nutritional impairment is common in cancer patients and is associated with poor outcomes. Only few studies focused on cachexia. We assessed the prevalence of cachexia in older cancer patients, identified associated risk factors, and evaluated its impact on 6 month overall mortality.<h4>Methods</h4>A French nationwide cross-sectional survey (performed in 55 geriatric oncology clinics) of older cancer patients aged ≥70 referred for geriatric assessment prior to treatment choice and initiation. Demographic, clinical, and nutritional data were collected. The first outcome was cachexia, defined as loss of more than 5% of bodyweight over the previous 6 months, or a body mass index below 20 kg/m<sup>2</sup> with weight loss of more than 2%, or sarcopenia (an impaired Strength, "],"journal":["Journal of cachexia, sarcopenia and muscle"],"pagination":["1477-1488"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8718093"],"repository":["biostudies-literature"],"pubmed_title":["Prevalence and prognostic impact of cachexia among older patients with cancer: a nationwide cross-sectional survey (NutriAgeCancer)."],"pmcid":["PMC8718093"],"pubmed_authors":["Medjenah H","Laurent M","Natella PA","de Decker L","Boulahssass R","Cattenoz C","Gisselbrecht M","Pamoukdjian F","Poisson J","Paillaud E","Geiss R","Liuu E","Guillem O","Heitz D","Gaxatte C","Albrand G","Antoine V","Canoui-Poitrine F","Chah Wakilian A","Falandry C","Couderc AL","Solem-Laviec H","Boudou-Rouquette P","Martinez-Tapia C"],"additional_accession":[]},"is_claimable":false,"name":"Prevalence and prognostic impact of cachexia among older patients with cancer: a nationwide cross-sectional survey (NutriAgeCancer).","description":"<h4>Background</h4>Nutritional impairment is common in cancer patients and is associated with poor outcomes. Only few studies focused on cachexia. We assessed the prevalence of cachexia in older cancer patients, identified associated risk factors, and evaluated its impact on 6 month overall mortality.<h4>Methods</h4>A French nationwide cross-sectional survey (performed in 55 geriatric oncology clinics) of older cancer patients aged ≥70 referred for geriatric assessment prior to treatment choice and initiation. Demographic, clinical, and nutritional data were collected. The first outcome was cachexia, defined as loss of more than 5% of bodyweight over the previous 6 months, or a body mass index below 20 kg/m<sup>2</sup> with weight loss of more than 2%, or sarcopenia (an impaired Strength, ","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Dec","modification":"2025-05-29T22:20:26.209Z","creation":"2025-05-29T22:20:26.209Z"},"accession":"S-EPMC8718093","cross_references":{"pubmed":["34519440"],"doi":["10.1002/jcsm.12776"]}}